Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer.

Front Oncol · 2017 · PMC5253386 · PMID 28168163

Europe PMC DOI

hedged sentence

0.4290

closest p · 8.6× alpha

0.4290

boldest claim

The sentences

did not reach statistical significancep = 0.429not close (p > 0.1)

The median survival for IIIB patients treated with IMRT was higher than those treated with 3D-CRT, but the data did not reach statistical significance (19.0 vs. 26.1 months, p = 0.429).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.